News >

Frontline Combos Significantly Improve Outcomes in Multiple Myeloma

Kristi Rosa
Published: Monday, Jul 08, 2019

Anastasios Raptis, MD

Anastasios Raptis, MD

The emergence of novel combinations in the frontline setting of multiple myeloma said led to significant survival gains, according to Anastasios Raptis, MD. Now, researchers are investigating if other promising approaches being explored in later lines of therapy, such as CAR T-cell therapy and bispecific T-cell engagers (BiTEs), could also be beneficial if moved upfront.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication
x